Home » Topics » Regulatory

Regulatory
RSS

Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease

Oct. 27, 2003

Starlix approved in combination with TZD for type 2 diabetes

Oct. 27, 2003

Approvable letter issued for Foradil Certihaler

Oct. 24, 2003

Approvable letter issued for expansion of Provigil labeling

Oct. 23, 2003

Once-weekly Enbrel approved

Oct. 23, 2003

Lexiva, the only protease inhibitor offering flexible dosing, approved in U.S.

Oct. 22, 2003

Paxil CR approved for social anxiety disorder

Oct. 22, 2003

FDA accepts for filing NDA for ultra-low-dose transdermal estrogen patch

Oct. 20, 2003

PEG-Intron Redipen approved by FDA

Oct. 15, 2003

Betaseron prefilled diluent syringe receives FDA approval

Oct. 15, 2003